title: Type I interferons mediate the innate cytokine response to recombinant fowlpox virus but not the induction of plasmacytoid dendritic cell-dependent adaptive immunity.
abstract: Type I interferons (IFNs) are considered to be important mediators of innate immunity due to their inherent antiviral activity, ability to drive the transcription of a number of genes involved in viral clearance, and their role in the initiation of innate and adaptive immune responses. Due to the central role of type I IFNs, we sought to determine their importance in the generation of immunity to a recombinant vaccine vector fowlpox virus (FPV). In analyzing the role of type I IFNs in immunity to FPV, we show that they are critical to the secretion of a number of innate and proinflammatory cytokines, including type I IFNs themselves as well as interleukin-12 (IL-12), tumor necrosis factor-alpha (TNF-alpha), IL-6, and IL-1beta, and that deficiency leads to enhanced virus-mediated antigen expression. Interestingly, however, type I IFNs were not required for adaptive immune responses to recombinant FPV even though plasmacytoid dendritic cells (pDCs), the primary producers of type I IFNs, have been shown to be requisite for this to occur. Furthermore, we provide evidence that the importance of pDCs may lie in their ability to capture and present virally derived antigen to T cells rather than in their capacity as professional type I IFN-producing cells.
authors.affiliation: Hanson Institute, SA Pathology, Adelaide, South Australia, Australia.
authors.forename: Erin L
authors.initials: EL
authors.lastname: Lousberg
authors.forename: Cara K
authors.initials: CK
authors.lastname: Fraser
authors.forename: Michael G
authors.initials: MG
authors.lastname: Tovey
authors.forename: Kerrilyn R
authors.initials: KR
authors.lastname: Diener
authors.forename: John D
authors.initials: JD
authors.lastname: Hayball
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D016207:Cytokines / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D005587:Fowlpox virus / Q000276:immunology*; D007370:Interferon Type I / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D016207:Cytokines; D007370:Interferon Type I; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
references.citation: J Biol Chem. 2005 May 13;280(19):18651-7
references.pmid: 15767254
references.citation: Cell Immunol. 2007 Apr;246(2):92-102
references.pmid: 17678637
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11349-53
references.pmid: 8876138
references.citation: Vaccine. 1988 Dec;6(6):466-8
references.pmid: 2854335
references.citation: J Exp Med. 1976 Nov 2;144(5):1316-23
references.pmid: 186555
references.citation: Blood. 2000 Nov 1;96(9):3029-39
references.pmid: 11049981
references.citation: Immunol Cell Biol. 2000 Apr;78(2):110-7
references.pmid: 10762410
references.citation: J Exp Med. 2003 Apr 7;197(7):885-98
references.pmid: 12682109
references.citation: Arch Virol. 1997;142(4):737-48
references.pmid: 9170501
references.citation: Biochem Pharmacol. 2008 Feb 1;75(3):589-602
references.pmid: 17868652
references.citation: Curr Opin Immunol. 2002 Feb;14(1):111-6
references.pmid: 11790540
references.citation: Blood. 2008 Nov 1;112(9):3713-22
references.pmid: 18698004
references.citation: Viral Immunol. 2007 Dec;20(4):531-40
references.pmid: 18158727
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12439-44
references.pmid: 18716002
references.citation: Ann N Y Acad Sci. 2008 Nov;1143:1-20
references.pmid: 19076341
references.citation: Nat Immunol. 2004 Dec;5(12):1219-26
references.pmid: 15549123
references.citation: Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
references.pmid: 11585785
references.citation: Immunol Cell Biol. 2008 Mar-Apr;86(3):239-45
references.pmid: 18180794
references.citation: J Exp Med. 2007 May 14;204(5):987-94
references.pmid: 17452523
references.citation: Curr Top Microbiol Immunol. 2007;316:337-57
references.pmid: 17969455
references.citation: Scand J Immunol. 2008 Mar;67(3):260-9
references.pmid: 18261039
references.citation: Nature. 2007 Jul 26;448(7152):501-5
references.pmid: 17618271
references.citation: Nat Immunol. 2008 May;9(5):551-7
references.pmid: 18376401
references.citation: J Immunol. 2007 Mar 1;178(5):3126-33
references.pmid: 17312160
references.citation: J Virol. 2009 Jun;83(11):5825-34
references.pmid: 19297490
references.citation: Allergy. 2009 May;64(5):702-9
references.pmid: 19383026
references.citation: J Cell Biochem. 2007 Dec 1;102(5):1087-94
references.pmid: 17910035
references.citation: Immunity. 2008 Sep 19;29(3):352-61
references.pmid: 18799143
references.citation: Eur J Immunol. 1990 Nov;20(11):2431-7
references.pmid: 2253683
references.citation: Expert Rev Vaccines. 2006 Aug;5(4):565-77
references.pmid: 16989636
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13631-6
references.pmid: 11095741
references.citation: Vaccine. 2008 Jul 4;26(29-30):3566-73
references.pmid: 18541346
references.citation: J Virol. 2007 Nov;81(22):12102-10
references.pmid: 17855554
references.citation: Nature. 2008 Feb 7;451(7179):725-9
references.pmid: 18256672
references.citation: J Exp Med. 2005 May 2;201(9):1435-46
references.pmid: 15851485
references.citation: Ann N Y Acad Sci. 2005 Nov;1056:218-33
references.pmid: 16387690
references.citation: J Immunol. 2009 Jun 15;182(12):8080-93
references.pmid: 19494334
references.citation: Nature. 2009 Mar 26;458(7237):514-8
references.pmid: 19158675
references.citation: J Immunol. 2004 Sep 15;173(6):4108-19
references.pmid: 15356161
references.citation: J Virol. 2006 Feb;80(3):1130-9
references.pmid: 16414990
references.citation: Immunity. 2003 Aug;19(2):225-34
references.pmid: 12932356
references.citation: J Exp Med. 2002 Apr 1;195(7):953-8
references.pmid: 11927638
references.citation: J Immunol. 2008 Oct 15;181(8):5775-84
references.pmid: 18832737
references.citation: Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):349-57
references.pmid: 12787571
references.citation: Nat Immunol. 2006 Jul;7(7):699-700
references.pmid: 16785884
references.citation: J Virol. 2007 Apr;81(7):3170-80
references.pmid: 17229689
references.citation: Blood. 2007 Jan 15;109(2):619-25
references.pmid: 16973959
references.citation: J Immunol. 2005 Nov 1;175(9):6032-41
references.pmid: 16237098
references.citation: Nat Protoc. 2007;2(9):2049-56
references.pmid: 17853860
references.citation: Cytokine Growth Factor Rev. 2008 Feb;19(1):3-19
references.pmid: 18248767
references.citation: Science. 1994 Jun 24;264(5167):1918-21
references.pmid: 8009221
references.citation: Nature. 2008 Mar 6;452(7183):103-7
references.pmid: 18288107
references.citation: Nature. 2005 Apr 7;434(7034):772-7
references.pmid: 15800576
references.citation: J Immunol. 2001 May 15;166(10):6099-103
references.pmid: 11342628
references.citation: Clin Microbiol Rev. 1997 Oct;10(4):611-36
references.pmid: 9336665
references.citation: J Biol Chem. 2001 Apr 27;276(17):13756-61
references.pmid: 11278812
references.citation: Exp Hematol. 2008 Jan;36(1):51-60
references.pmid: 17949888
references.citation: Biochimie. 2007 Jun-Jul;89(6-7):843-55
references.pmid: 17544561
references.citation: Cell Res. 2005 Jun;15(6):407-22
references.pmid: 15987599
references.citation: J Immunol Methods. 1994 May 2;171(1):131-7
references.pmid: 8176234
references.citation: Antimicrob Agents Chemother. 2005 Oct;49(10):3991-6
references.pmid: 16189071
references.citation: J Infect Chemother. 2008 Apr;14(2):86-92
references.pmid: 18622669
references.citation: J Exp Med. 2002 Feb 18;195(4):507-16
references.pmid: 11854363